Leukemia Clinical Trials

Showing 5141-5160 of 10,987 trials

Pembrolizumab as Neoadjuvant Therapy for Resectable Stage IA3 to IIA Non-Small Cell Lung Cancer (NSCLC)

NCT04638582

This is a prospective, randomized, single-site, open-label Phase II trial of neoadjuvant pembrolizumab (3 cycles) followed by surgery, versus concomitant neoadjuvant pembrolizumab with platinum doublet chemotherapy (3 cycles) followed by surgery for participants with Stage IA3, IB and IIA non-small-cell lung cancer (NSCLC). Participants will be offered pembrolizumab (6 cycles), and standard of care adjuvant chemotherapy (4 cycles) if applicable.

Lung Cancer, Nonsmall Cell

McGill University Health Centre/Research Institute of the McGill University Health Centre44 participantsStarted Aug 2022

Montreal, Quebec, Canada

WITHDRAWNNA

Short Atrioventricular Delay Pacing

NCT01233661

We intend to examine the effects of temporary elevation of atrial wall stress by shortening of the atrioventricular delay in patients with dual-chamber pacemakers.

Chronically (i.e. Implanted for at Least Six Months) Dual-chamber PacemakerStable Cardiac Status (i.e. no Hospitalizations or Cardiac Medication Changes Within 3 Months)

University of PittsburghStarted Jan 2011

Pittsburgh, Pennsylvania, United States

COMPLETED

Prevalence, Etiology and Effects on Oral Health and Life Quality of Molar Incisor Hypomineralization

NCT05779332

Molar incisor hypomineralization (MIH) can lead to many clinical conditions and affect oral health-related quality of life (OHRQoL).

Molar Incisor HypomineralizationOral HealthChild, Only+4 more

Recep Tayyip Erdogan University Training and Research Hospital655 participantsStarted Feb 2020

Rize, Turkey (Türkiye)

Pembrolizumab as Neoadjuvant Therapy for Resectable Stage IA3 to IIA Non-Small Cell Lung Cancer (NSCLC)

Short Atrioventricular Delay Pacing

Prevalence, Etiology and Effects on Oral Health and Life Quality of Molar Incisor Hypomineralization

Related Searches

Piloting the Feasibility of FLT-PET/CT Non-Small Cell Lung Cancer Managed With SBRT

G-CSF+DAC+BUCY vs G-CSF+DAC+BF Conditioning Regimen for High-risk MDS Undergoing Allo-HSCT

German Multicenter Trial for Treatment of Elderly Patients With Newly Diagnosed Acute Lymphoblastic Leukemia

Upfront Resection of Locally Advanced NSCLC Followed by Chemoradiotherapy

(EXPLORER) Study of BLU-285 in Patients With Advanced Systemic Mastocytosis (AdvSM) and Relapsed or Refractory Myeloid Malignancies

Treatment of Hyperuricemia With Rasburicase in Patients With Acute Lymphoblastic Leukemia or High Grade Lymphoma

First Line Osimertinib for EGFR Mutation-positive Non-Small Cell Lung Cancer in Real World Chinese Setting

Organ Preservation in Rectal Cancer: Contact X-ray Brachytherapy vs Extending the Waiting Interval and Local Excision

A Single-Center, Phase 2 Study Evaluating Bilastine Ophthalmic Solution in the CAC® Model

A Study Evaluating Bilastine Ophthalmic Solution 0.6% in the Conjunctival Allergen Challenge (Ora-CAC®) Model.

A Prospective Multicenter Clinical Trial of MRD-based Treatment Strategy in Children and Young Adults With AML

Rituximab Plus Venetoclax in Combination With Zandelisib in Subjects With CLL

Changing Over Time of Ascorbic Acid After Chemotherapy

Oral Clofarabine for Relapsed/Refractory Non-Hodgkin Lymphoma

A RCT Study of ERAS in Infants With Choledochal Cyst

A Study of Atezolizumab (MPDL3280A) Compared With a Platinum Agent (Cisplatin or Carboplatin) + (Pemetrexed or Gemcitabine) in Participants With Stage IV Non-Squamous or Squamous Non-Small Cell Lung Cancer (NSCLC) [IMpower110]

A Clinical Study of 6MW3211 Monotherapy or Combination Therapy for AML or MDS